mTORC1/2 Inhibition Re-Sensitizes Platinum-Resistant Ovarian Cancer by Disrupting Selective Translation of DNA Damage and Survival mRNAs
Oncotarget - United States
doi 10.18632/oncotarget.25869
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 23, 2018
Authors
Publisher
Impact Journals, LLC